Amedeo Smart

Free Medical Literature Service


 

Amedeo

Depression

  Free Subscription

Articles published in
Can J Psychiatry
    November 2024
  1. ABBASS A, Luyten P, Leichsenring F
    Short-Term Psychodynamic Psychotherapy is the First-Line Option for Depression and Treatment Resistant Depression According to Available Evidence.
    Can J Psychiatry. 2024 Nov 18:7067437241299487. doi: 10.1177/07067437241299487.
    >> Share

    October 2024
  2. MAN LLY, Rotenberg M, Andari S, Wells S, et al
    Eco-Depression and Eco-Anxiety Among Youth: A Sex and Gender Analysis.
    Can J Psychiatry. 2024 Oct 1:7067437241287153. doi: 10.1177/07067437241287153.
    >> Share

    September 2024
  3. BECK K, Young AH
    Commentary on the Canadian Network for Mood and Anxiety Treatments 2023 Clinical Guidelines for Management of Major Depressive Disorder in Adults - Capturing the State of the Art.
    Can J Psychiatry. 2024;69:692-694.
    >> Share

  4. LAM RW, Kennedy SH, Adams C, Bahji A, et al
    Canadian Network for Mood and Anxiety Treatments (CANMAT) 2023 Update on Clinical Guidelines for Management of Major Depressive Disorder in Adults: Reseau canadien pour les traitements de l'humeur et de l'anxiete (CANMAT) 2023 : Mise a jour des lignes
    Can J Psychiatry. 2024;69:641-687.
    >> Share

    July 2024
  5. THERRIEN F, Ward C, Chokka P, Habert J, et al
    Adjunctive Brexpiprazole for Patient Life Engagement in Major Depressive Disorder: A Canadian, Phase 4, Open-Label, Interventional Study: Brexpiprazole d'appoint pour l'engagement dans la vie des patients souffrant de trouble depressif majeur: une etu
    Can J Psychiatry. 2024;69:513-523.
    >> Share

  6. MOINUL D, Hao C, Dimitropoulos G, Taylor VH, et al
    Patient Perceptions of Microbiome-Based Therapies as Novel Treatments for Mood Disorders: A Mixed Methods Study: Perceptions des patients sur les therapies basees sur le microbiome pour les troubles de l'humeur : une etude a methodes mixtes.
    Can J Psychiatry. 2024;69:503-512.
    >> Share

    June 2024
  7. CHEN Y, Zhao J, Wang J, Peng L, et al
    Effect of Bright Light Therapy on Perinatal Depression: A Systematic Review and Meta-Analysis: Effet de la luminotherapie sur la depression perinatale: une revue systematique et une meta-analyse.
    Can J Psychiatry. 2024 Jun 11:7067437241248051. doi: 10.1177/07067437241248051.
    >> Share

    May 2024
  8. WONG M, Kiss A, Herrmann N, Lanctot KL, et al
    Modifiable Risk Factors Associated With Cognitive Decline in Late Life Depression: Findings From the Canadian Longitudinal Study on Aging: Facteurs de risque modifiables associes au declin cognitif dans la depression en fin de vie : constatations de l
    Can J Psychiatry. 2024 May 15:7067437241255095. doi: 10.1177/07067437241255095.
    >> Share

    April 2024
  9. SCHELL C, Quilty LC, Cunningham JA
    Investigating Alexithymia as a Moderator of Outcomes in a Randomized Controlled Trial of an Online Intervention for Co-Occurring Depression and Hazardous Alcohol Use: Enquete sur l'alexithymie en tant que moderateur des resultats dans un essai randomi
    Can J Psychiatry. 2024 Apr 29:7067437241249412. doi: 10.1177/07067437241249412.
    >> Share

  10. BERK M, Agustini B, Forbes M, Jacka FN, et al
    Canadian Network for Mood and Anxiety Treatments (CANMAT) 2023: Towards Personalized Approaches to Depression Treatment.
    Can J Psychiatry. 2024 Apr 22:7067437241248087. doi: 10.1177/07067437241248087.
    >> Share

  11. LI VW, Sahota J, Dev DK, Gill DD, et al
    A Randomized Evaluation of MoodFX, a Patient-Centred e-Health Tool to Support Outcome Measurement for Depression: Une evaluation randomisee de MoodFX, un outil de sante en ligne centre sur le patient pour soutenir la mesure du resultat dans la depress
    Can J Psychiatry. 2024 Apr 11:7067437241245331. doi: 10.1177/07067437241245331.
    >> Share

  12. WANG T, Gao C, Li J, Li L, et al
    Prediction of Early Antidepressant Efficacy in Patients with Major Depressive Disorder Based on Multidimensional Features of rs-fMRI and P11 Gene DNA Methylation: Prediction de l'efficacite precoce d'un antidepresseur chez des patients souffrant du tr
    Can J Psychiatry. 2024;69:264-274.
    >> Share

    February 2024
  13. JALALI S, Liu L, Wang J, Kennedy SH, et al
    Factors Associated with Transition to Serious Mental Illness.
    Can J Psychiatry. 2024;69:79-88.
    >> Share

  14. LAPOSA JM, Cameron D, Corace K, Quick N, et al
    A Rapid Access Brief Psychotherapy Intervention to Respond to Healthcare Workers in Ontario Whose Mental Health was Negatively Impacted During the COVID-19 Pandemic.
    Can J Psychiatry. 2024;69:89-99.
    >> Share

    December 2023
  15. LAI KSP, Waxman R, Blumberger DM, Giacobbe P, et al
    Competencies for Repetitive Transcranial Magnetic Stimulation in Postgraduate Medical Education: Expert Consensus Using a Modified Delphi Process.
    Can J Psychiatry. 2023;68:916-924.
    >> Share

    November 2023
  16. KHAN I, Chawla N
    Comments on "A Collaborative-Care Telephone-Based Intervention for Depression, Anxiety, and at-Risk Drinking in Primary Care: The PARTNERs Randomized Clinical Trial".
    Can J Psychiatry. 2023 Nov 22:7067437231216175. doi: 10.1177/07067437231216175.
    >> Share

  17. PINTO JV, Crippa JAS, Cereser KM, Vianna-Sulzbach MF, et al
    Cannabidiol as an Adjunctive Treatment for Acute Bipolar Depression: A Pilot Study.
    Can J Psychiatry. 2023 Nov 3:7067437231209650. doi: 10.1177/07067437231209650.
    >> Share

    October 2023
  18. ISLAM F, Magarbeh L, Elsheikh SSM, Kloiber S, et al
    Influence of CYP2C19, CYP2D6, and ABCB1 Gene Variants and Serum Levels of Escitalopram and Aripiprazole on Treatment-Emergent Sexual Dysfunction: A Canadian Biomarker Integration Network in Depression 1 (CAN-BIND 1) Study.
    Can J Psychiatry. 2023 Oct 5:7067437231203433. doi: 10.1177/07067437231203433.
    >> Share

    September 2023
  19. ANDREWS KL, Jamshidi L, Nisbet J, Brunet A, et al
    Potentially Psychologically Traumatic Event Exposure Histories of new Royal Canadian Mounted Police Cadets.
    Can J Psychiatry. 2023;68:663-681.
    >> Share

    August 2023
  20. BASTIEN G, McAnulty C, Ledjiar O, Socias ME, et al
    Effects of Buprenorphine/Naloxone and Methadone on Depressive Symptoms in People with Prescription Opioid Use Disorder: A Pragmatic Randomised Controlled Trial.
    Can J Psychiatry. 2023;68:572-585.
    >> Share

    May 2023
  21. TOURJMAN SV, Buck G, Jutras-Aswad D, Khullar A, et al
    Canadian Network for Mood and Anxiety Treatments (CANMAT) Task Force Report: A Systematic Review and Recommendations of Cannabis use in Bipolar Disorder and Major Depressive Disorder.
    Can J Psychiatry. 2023;68:299-311.
    >> Share

    April 2023
  22. ADHIKARI K, Racine N, Hetherington E, McDonald S, et al
    Women's Mental Health up to Eight Years after Childbirth and Associated Risk Factors: Longitudinal Findings from the All Our Families Cohort in Canada.
    Can J Psychiatry. 2023;68:269-282.
    >> Share

  23. WOOD-ROSS C, Tran T, Milanovic M, Jokic R, et al
    Neurocognition and Depressive Symptoms have Unique Pathways to Predicting Different Domains of Functioning in Major Depressive Disorder.
    Can J Psychiatry. 2023;68:241-248.
    >> Share

    February 2023
  24. ISHRAT HUSAIN M, Rodie DJ, Perivolaris A, Sanches M, et al
    A Collaborative-Care Telephone-Based Intervention for Depression, Anxiety, and at-Risk Drinking in Primary Care: The PARTNERs Randomized Clinical Trial.
    Can J Psychiatry. 2023 Feb 28:7067437231156243. doi: 10.1177/07067437231156243.
    >> Share

  25. HARKNESS KL, Chakrabarty T, Rizvi SJ, Mazurka R, et al
    The Differential Relation of Emotional, Physical, and Sexual Abuse Histories to Antidepressant Treatment Remission and Persistence of Anhedonia in Major Depression: A CAN-BIND-1 Report.
    Can J Psychiatry. 2023 Feb 13:7067437231156255. doi: 10.1177/07067437231156255.
    >> Share

    January 2023
  26. GREEN JE, Berk M, Mohebbi M, Loughman A, et al
    Feasibility, Acceptability, and Safety of Faecal Microbiota Transplantation in the Treatment of Major Depressive Disorder: A Pilot Randomized Controlled Trial.
    Can J Psychiatry. 2023 Jan 13:7067437221150508. doi: 10.1177/07067437221150508.
    >> Share

  27. ROSENBLAT JD, Husain MI, Lee Y, McIntyre RS, et al
    The Canadian Network for Mood and Anxiety Treatments (CANMAT) Task Force Report: Serotonergic Psychedelic Treatments for Major Depressive Disorder.
    Can J Psychiatry. 2023;68:5-21.
    >> Share

    November 2022
  28. SLOMP C, Morris E, Edwards L, Hoens AM, et al
    Pharmacogenomic Testing for Major Depression: A Qualitative Study of the Perceptions of People with Lived Experience and Professional Stakeholders.
    Can J Psychiatry. 2022 Nov 28:7067437221140383. doi: 10.1177/07067437221140383.
    >> Share

  29. KAHAWAGE P, Bullock B, Meyer D, Gottlieb J, et al
    Social Rhythm Disruption is Associated with Greater Depressive Symptoms in People with Mood Disorders: Findings from a Multinational Online Survey During COVID-19.
    Can J Psychiatry. 2022;67:831-840.
    >> Share

    August 2022
  30. THATIKONDA NS, Vinod P, Balachander S, Bhaskarpillai B, et al
    Efficacy of Repetitive Transcranial Magnetic Stimulation on Comorbid Anxiety and Depression Symptoms in Obsessive-Compulsive Disorder: A Meta-Analysis of Randomized Sham-Controlled Trials.
    Can J Psychiatry. 2022 Aug 22:7067437221121112. doi: 10.1177/07067437221121112.
    >> Share

    May 2022
  31. DO A, Li VW, Huang S, Michalak EE, et al
    Blue-Light Therapy for Seasonal and Non-Seasonal Depression: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Can J Psychiatry. 2022 May 6:7067437221097903. doi: 10.1177/07067437221097903.
    >> Share

  32. BONARDI O, Wang Y, Li K, Jiang X, et al
    Effects of COVID-19 Mental Health Interventions Among Children, Adolescents, and Adults Not Quarantined or Undergoing Treatment Due to COVID-19 Infection: A Systematic Review of Randomised Controlled Trials.
    Can J Psychiatry. 2022;67:336-350.
    >> Share

  33. GOEGAN SA, Hasey GM, King JP, Losier BJ, et al
    Naturalistic Study on the Effects of Electroconvulsive Therapy (ECT) on Depressive Symptoms.
    Can J Psychiatry. 2022;67:351-360.
    >> Share

    April 2022
  34. DIEP C, Bhat V, Wijeysundera DN, Clarke HA, et al
    The Association between Recent Cannabis Use and Suicidal Ideation in Adults: A Population-based Analysis of the NHANES from 2005 to 2018.
    Can J Psychiatry. 2022;67:259-267.
    >> Share

    March 2022
  35. VASILIADIS HM, Lamoureux-Lamarche C, Grenier S, Roberge P, et al
    Minimally Adequate Treatment for Depression and Anxiety Associated With Mortality in Primary Care Older Adults.
    Can J Psychiatry. 2022 Mar 7:7067437221082883. doi: 10.1177/07067437221082883.
    >> Share

  36. XI C, Liu Z, Zeng C, Tan W, et al
    The centrality of working memory networks in differentiating bipolar type I depression from unipolar depression: A task-fMRI study.
    Can J Psychiatry. 2022 Mar 4:7067437221078646. doi: 10.1177/07067437221078646.
    >> Share

    January 2022
  37. VAN LIESHOUT RJ, Layton H, Savoy CD, Haber E, et al
    Public Health Nurse-delivered Group Cognitive Behavioural Therapy for Postpartum Depression: A Randomized Controlled Trial.
    Can J Psychiatry. 2022 Jan 21:7067437221074426. doi: 10.1177/07067437221074426.
    >> Share

  38. BENOIT JRA, Dursun SM, Greiner R, Cao B, et al
    Using Machine Learning to Predict Remission in Patients With Major Depressive Disorder Treated With Desvenlafaxine.
    Can J Psychiatry. 2022;67:39-47.
    >> Share

    November 2021
  39. SAREEN J, Bolton SL, Mota N, Afifi TO, et al
    Lifetime Prevalence and Comorbidity of Mental Disorders in the Two-wave 2002-2018 Canadian Armed Forces Members and Veterans Mental Health Follow-up Survey (CAFVMHS): Prevalence et Comorbidite de Duree de vie Des Troubles Mentaux Dans l'Enquete de Sui
    Can J Psychiatry. 2021;66:951-960.
    >> Share

  40. AFIFI TO, Sareen J, Taillieu T, Stewart-Tufescu A, et al
    Association of Child Maltreatment and Deployment-related Traumatic Experiences with Mental Disorders in Active Duty Service Members and Veterans of the Canadian Armed Forces: Association de la Maltraitance des Enfants et des Experiences Traumatisantes
    Can J Psychiatry. 2021;66:961-970.
    >> Share

    October 2021
  41. SARRIS J, Marx W, Ashton MM, Ng CH, et al
    Plant-based Medicines (Phytoceuticals) in the Treatment of Psychiatric Disorders: A Meta-review of Meta-analyses of Randomized Controlled Trials: Les medicaments a base de plantes (phytoceutiques) dans le traitement des troubles psychiatriques: une me
    Can J Psychiatry. 2021;66:849-862.
    >> Share

    September 2021
  42. BULLOCH A, Zulyniak S, Williams J, Bajgai J, et al
    Poor Mental Health during the COVD-19 Pandemic: Effect Modification by Age.
    Can J Psychiatry. 2021;66:827-829.
    >> Share

  43. MCINERNEY SJ, Chakrabarty T, Maciukiewicz M, Frey BN, et al
    Cognition and Its Association with Psychosocial and Occupational Functioning during Treatment with Escitalopram in Patients with Major Depressive Disorder: A CAN-BIND-1 Report: La Cognition Et Son Association Avec Le Fonctionnement Psychosocial Et Pro
    Can J Psychiatry. 2021;66:798-806.
    >> Share

    June 2021
  44. WONG SMY, Hui CLM, Wong CSM, Suen YN, et al
    Mental Health Risks after Repeated Exposure to Multiple Stressful Events during Ongoing Social Unrest and Pandemic in Hong Kong: The Role of Rumination: Risques pour la sante mentale apres une exposition repetee a de multiples evenements stressants d'
    Can J Psychiatry. 2021;66:577-585.
    >> Share

  45. ZARATE CA JR
    Commentary on the Canadian Network for Mood and Anxiety Treatments (CANMAT) Task Force Recommendations for the Use of Racemic Ketamine in Adults with Major Depressive Disorder.
    Can J Psychiatry. 2021;66:537-539.
    >> Share

    April 2021
  46. VAIDYAM AN, Linggonegoro D, Torous J
    Changes to the Psychiatric Chatbot Landscape: A Systematic Review of Conversational Agents in Serious Mental Illness: Changements du paysage psychiatrique des chatbots: une revue systematique des agents conversationnels dans la maladie mentale serieus
    Can J Psychiatry. 2021;66:339-348.
    >> Share

    March 2021
  47. MORTON E, Michalak EE, Levitt A, Levitan RD, et al
    Quality of Life Impacts of Bright Light Treatment, Fluoxetine, and the Combination in Patients with Nonseasonal Major Depressive Disorder: A Randomized Clinical Trial.
    Can J Psychiatry. 2021;66:289-297.
    >> Share

    February 2021
  48. SWAINSON J, McGirr A, Blier P, Brietzke E, et al
    The Canadian Network for Mood and Anxiety Treatments (CANMAT) Task Force Recommendations for the Use of Racemic Ketamine in Adults with Major Depressive Disorder: Recommandations Du Groupe De Travail Du Reseau Canadien Pour Les Traitements De L'humeur
    Can J Psychiatry. 2021;66:113-125.
    >> Share

  49. BHARGAV PH, Reddy PV, Govindaraj R, Gulati K, et al
    Impact of a Course of Add-on Supervised Yoga on Cortical Inhibition in Major Depressive Disorder: A Randomized Controlled Trial.
    Can J Psychiatry. 2021;66:179-181.
    >> Share

  50. BARTOLI F, Bachi B, Calabrese A, Moretti F, et al
    Cannabidiol for Mood Disorders: A Call for More Research.
    Can J Psychiatry. 2021;66:182-183.
    >> Share

    January 2021
  51. ENNS MW, Mota N, Afifi TO, Bolton SL, et al
    Course and Predictors of Major Depressive Disorder in the Canadian Armed Forces Members and Veterans Mental Health Follow-up Survey: Cours et Predicteurs du Trouble de Depression Majeure Dans l'Enquete de Suivi Sur la Sante Mentale Aupres Des Membres
    Can J Psychiatry. 2021 Jan 7:706743720984677. doi: 10.1177/0706743720984677.
    >> Share

  52. LEMIEUX R, Garon-Bissonnette J, Loiselle M, Martel E, et al

    Can J Psychiatry. 2021;66:34-42.
    >> Share

  53. SMITH PM, Oudyk J, Potter G, Mustard C, et al
    The Association between the Perceived Adequacy of Workplace Infection Control Procedures and Personal Protective Equipment with Mental Health Symptoms: A Cross-sectional Survey of Canadian Health-care Workers during the COVID-19 Pandemic: L'associatio
    Can J Psychiatry. 2021;66:17-24.
    >> Share

  54. MURRAY G, Gottlieb J, Swartz HA
    Maintaining Daily Routines to Stabilize Mood: Theory, Data, and Potential Intervention for Circadian Consequences of COVID-19.
    Can J Psychiatry. 2021;66:9-13.
    >> Share

    November 2020
  55. LI A, Rosella LC, Kurdyak P, Wodchis WP, et al
    Depression as a Risk Factor for Physical Illness and Multimorbidity in a Cohort with No Prior Comorbidity: La Depression Comme Facteur de Risque de Maladie Physique et de Multimorbidite Dans Une Cohorte Sans Comorbidite Anterieure.
    Can J Psychiatry. 2020 Nov 26:706743720974832. doi: 10.1177/0706743720974832.
    >> Share

  56. BAHJI A, Ermacora D, Stephenson C, Hawken ER, et al
    Comparative Efficacy and Tolerability of Adjunctive Pharmacotherapies for Acute Bipolar Depression: A Systematic Review and Network Meta-analysis: Efficacite Et Tolerabilite Comparatives Des Pharmacotherapies D'appoint Pour La Depression Bipolaire Aig
    Can J Psychiatry. 2020 Nov 11:706743720970857. doi: 10.1177/0706743720970857.
    >> Share

    October 2020
  57. THOMBS BD, Levis B, Lyubenova A, Neupane D, et al
    Overestimation of Postpartum Depression Prevalence Based on a 5-item Version of the EPDS: Systematic Review and Individual Participant Data Meta-analysis.
    Can J Psychiatry. 2020 Oct 26:706743720934959. doi: 10.1177/0706743720934959.
    >> Share

  58. SCHMITZ N, Holley P, Meng X, Fish L, et al
    COVID-19 and Depressive Symptoms: A Community-based Study in Quebec, Canada.
    Can J Psychiatry. 2020;65:733-735.
    >> Share

  59. ZHOU L, Xie RH, Yang X, Zhang S, et al
    Feasibility and Preliminary Results of Effectiveness of Social Media-based Intervention on the Psychological Well-being of Suspected COVID-19 Cases during Quarantine.
    Can J Psychiatry. 2020;65:736-738.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016